Ms. Gibson, author of the book China Rx: Exposing the Risks of America’s Dependence on China for Medicine, told WCNC that because China has already stopped companies that make surgical masks and protective medical gear from exporting those items to other countries, it is likely the country would do the same for drugs if the coronavirus outbreak doesn’t taper.
China produces most of the active pharmaceutical ingredients the U.S. uses to make generic drugs. Generic drugs account for 90 percent of the drugs the U.S. uses, Ms. Gibson said.
“China makes about 90 percent of the production for the medicines for people who might end up in the hospital for coronavirus,” she told WCNC.
She added that the U.S. doesn’t have the capacity to quickly produce the drugs a hospital would need if a severe coronavirus outbreak happened in the U.S.
Read the full article here.
More articles on pharmacy:
21 states reject $18B opioid settlement offer from McKesson, Cardinal, AmerisourceBergen
BCBS responds to physician pushback on mail-order pharmacy plan
The 20 most expensive drugs in the US in 2020
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.